LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

Clinical trial NCT06303713 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06303713
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2024-05-22
Primary completion: 2026-10-19
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.